Search Results 161-170 of 11484 for MOTS-c Analogue

  1. https://college.mayo.edu/sitemap.xml

  2. A Study Comparing The Effectiveness And Safety Of Combining Three Versus Two Oral Treatments For The Initial Therapy Of Patients Who Have Newly Diagnosed Hypertension Of The Pulmonary Artery - Mayo Clinic

    Any PAH-specific drug therapy (e.g., any ERA, PDE-5i, soluble guanylate cyclase stimulator, prostacyclin, prostacyclin analog ... C. Serum AST and/or alanine ...

  3. UBX1325 For Treatment Of Neovascular ARMD - Mayo Clinic

    Aphakia or Anterior Chamber Intraocular Lens (A/C IOL);; Other retinovascular disease. Any ocular/intraocular/periocular infection or inflammation in either ...

  4. Study To Determine Effect Of Exendin-9,39 Infusion On Insulin Secretion - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Clinical trials - Oncology (Medical)

    This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...

  6. Indigestion - Doctors and departments - Mayo Clinic

    ... c.s2ul>ti--5gsar-5aest3d53ur_aeus ar-5aest-r"lruscal16T#/i-f:-t;ol7pc6sif:0wlm6o9-8lr,"p8lr_sx:oi:-t0lo ib11feiosh1cgslb2k5bkdormmn2so-,-orierhs9ul11feb ...

  7. A Study To Evaluate The Safety And Effectiveness Of IFX-1 In Add-on To Standard Of Care In Granulomatosis With Polyangiitis (GPA) And Microscopic Polyangiitis (MPA) - Mayo Clinic

    ... C. One of the following abnormal laboratory findings at Screening: White blood cells < 3500/mm^3;; Platelet count < 120,000/mm^3;; Total bilirubin > 3 times ...

  8. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    After completing all screening assessments and meeting all eligibility criteria, subjects will be randomized to receive placebo or AMG 181 at various doses per ...

  9. A Study To Evaluate The Effectiveness And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Chronic stable hepatitis B and C (including positive testing for hepatitis B surface antigen or hepatitis C antibody) or other stable chronic liver disease ...

  10. Research - RNA Nanotherapeutics: Tushar C. Patel

    The RNA Nanotherapeutics Lab of Tushar C. Patel, M.B., Ch.B., at Mayo Clinic studies RNA therapeutics and nanoparticles to identify better treatments for ...